Exact Mass: 623.2802436000001

Exact Mass Matches: 623.2802436000001

Found 40 metabolites which its exact mass value is equals to given mass value 623.2802436000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Leukotriene C5

(5S,6R,7E,9E,11Z,14Z,17Z)-6-{[(2R)-2-{[(4R)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulphanyl}-5-hydroxyicosa-7,9,11,14,17-pentaenoic acid

C30H45N3O9S (623.287636)

Leukotriene C5 is a slow reacting substance derived from eicosapentaenoic acid.Leukotriene C5 has similar biological activity on the isolated guinea pig ileum but is less potent than is leukotriene C4. Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Leukotriene C5 is a slow reacting substance derived from eicosapentaenoic acid.Leukotriene C5 has similar biological activity on the isolated guinea pig ileum but is less potent than is leukotriene C4.

Gln Gln Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H37N7O8 (623.2703482000001)

Gln Gln Tyr Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C30H37N7O8 (623.2703482000001)

Gln Trp Gln Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H37N7O8 (623.2703482000001)

Gln Trp Tyr Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C30H37N7O8 (623.2703482000001)

Gln Tyr Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C30H37N7O8 (623.2703482000001)

Gln Tyr Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C30H37N7O8 (623.2703482000001)

Trp Gln Gln Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H37N7O8 (623.2703482000001)

Trp Gln Tyr Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C30H37N7O8 (623.2703482000001)

Trp Tyr Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C30H37N7O8 (623.2703482000001)

Tyr Gln Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C30H37N7O8 (623.2703482000001)

Tyr Gln Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C30H37N7O8 (623.2703482000001)

Tyr Trp Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C30H37N7O8 (623.2703482000001)

TIDFE

Thr Ile Asp Phe Glu

C28H41N5O11 (623.2802436000001)

TFDEI

Thr Phe Asp Glu Ile

C28H41N5O11 (623.2802436000001)

15dPGJ2-GS

11-oxo-9-(S-glutathionyl)-5Z,12E,14E-prostatetraenoic acid

C30H45N3O9S (623.287636)

Triamcinolone Benetonide

C35H42FNO8 (623.2894304)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

15-deoxy-Delta12,14-Prostaglandin J2 Glutathione

C30H45N3O9S (623.287636)

leukotriene C4(2-)

C30H45N3O9S-2 (623.287636)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

4-chloro-N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C31H46ClN3O6S (623.2795686000001)

4-chloro-N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C31H46ClN3O6S (623.2795686000001)

4-chloro-N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C31H46ClN3O6S (623.2795686000001)

4-chloro-N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C31H46ClN3O6S (623.2795686000001)

4-chloro-N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C31H46ClN3O6S (623.2795686000001)

4-chloro-N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzenesulfonamide

C31H46ClN3O6S (623.2795686000001)

Leukotriene C5

C30H45N3O9S (623.287636)

leukotriene C4(2-)

C30H45N3O9S (623.287636)

The leukotriene anion that is the dianion of leukotriene C4 arising from deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group.

LNAPS 25:7

C31H46NO10P (623.2859186)

PS 14:0/7:3;O3

C27H46NO13P (623.2706636)

PS 14:1/7:2;O3

C27H46NO13P (623.2706636)

PS 21:3;O3

C27H46NO13P (623.2706636)

ST 29:6;O7;Tau

C31H45NO10S (623.2764030000001)

5'-O-DMT-N6-ibu-dA

C35H37N5O6 (623.2743702)

5'-O-DMT-N6-ibu-dA can be used in the synthesis of oligodeoxyribonucleotides[1].

(1s,2r,3s,4s,5s,7r,9s,10r,11s,14r)-7-(acetyloxy)-5,9-dimethyl-8-oxo-11-(prop-1-en-2-yl)-2,4-bis(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C34H41NO10 (623.2730326000001)

7-(acetyloxy)-5,9-dimethyl-8-oxo-11-(prop-1-en-2-yl)-2,4-bis(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C34H41NO10 (623.2730326000001)

(7e,12s,13s,14r,15r,16r,17s,18s,19e,21z)-2,4,13,15,17,23-hexahydroxy-3,7,12,14,16,18,22-heptamethyl-10-oxa-24-azatetracyclo[23.3.1.0⁵,²⁸.0⁹,¹¹]nonacosa-1(28),2,4,7,19,21,23,25-octaene-6,27,29-trione

(7e,12s,13s,14r,15r,16r,17s,18s,19e,21z)-2,4,13,15,17,23-hexahydroxy-3,7,12,14,16,18,22-heptamethyl-10-oxa-24-azatetracyclo[23.3.1.0⁵,²⁸.0⁹,¹¹]nonacosa-1(28),2,4,7,19,21,23,25-octaene-6,27,29-trione

C34H41NO10 (623.2730326000001)